Patents Assigned to Medico Consl Co., Ltd
  • Patent number: 11058718
    Abstract: Provided is a method for treating non-alcoholic steatohepatitis (NASH), the method includes administering to a subject in need thereof a therapeutically effective amount of a pharmaceutical composition and the pharmaceutical composition contains polaprezinc as zinc preparation and sodium selenite as selenium preparation.
    Type: Grant
    Filed: June 4, 2020
    Date of Patent: July 13, 2021
    Assignee: MEDICO CONSL CO., LTD.
    Inventors: Satoru Kubota, Toru Kono
  • Publication number: 20200405754
    Abstract: Provided is a method for treating non-alcoholic steatohepatitis (NASH), the method includes administering to a subject in need thereof a therapeutically effective amount of a pharmaceutical composition and the pharmaceutical composition contains polaprezinc as zinc preparation and sodium selenite as selenium preparation.
    Type: Application
    Filed: June 4, 2020
    Publication date: December 31, 2020
    Applicant: Medico Consl Co., Ltd.
    Inventors: Satoru KUBOTA, Toru KONO
  • Publication number: 20190336523
    Abstract: Problem to be Solved To provide medicine and health food suitable for treatment and prevention for non-alcoholic fatty liver disease (NAFLAD) and/or non-alcoholic steatohepatitis (NASH) which are not involved with hepatic virus, and/or hepatic fatty degeneration. Means for solving the problem A combination drug suitable for treatment of non-alcoholic fatty liver disease (NAFLAD) and/or non-alcoholic steatohepatitis (NASH), and/or hepatic fatty degeneration, wherein the active ingredients are zinc preparation and selenium preparation.
    Type: Application
    Filed: November 30, 2017
    Publication date: November 7, 2019
    Applicant: Medico Consl Co., Ltd
    Inventors: Satoru KUBOTA, Toru KONO